Table 6.
Univariate Analysis of Risk Factors for aGVHD
| Variable | P | HR (95% CI) |
|---|---|---|
| Age | 0.615 | 0.99(0.96–1.02) |
| HLA match (matched vs haplo-matched) | 0.125 | 1.80(0.85–3.83) |
| ATG in conditioning (negative vs positive) | 0.066 | 2.10(0.95–4.63) |
| Graft dose | ||
| CD34+cell | 0.492 | 0.99(0.73–1.16) |
| MNC | 0.678 | 1.03(0.91–1.15) |
| NK30 (low vs high) | <0.01 | 0.21(0.10–0.44) |
| NK60 (low vs high) | 0.019 | 0.42(0.20–0.87) |
| CD3+T30 | 0.387 | 1.00(0.99–1.00) |
| CD4+T30 | 0.258 | 0.99(0.99–1.00) |
| CD8+T30 | 0.344 | 0.99(0.99–1.00) |
Abbreviations: aGVHD, Acute graft vs host disease; HR, Hazard ratio; HLA, Human leukocyte antigens; ATG, Anti-thymocyte globulin; MNC, Mononuclear cell.